| Dlr Family Medicine Medical Group Pc | |
|
11985 4th St Ste 102 Yucaipa CA 92399-2727 | |
| (909) 478-7951 | |
| Not Available |
| Full Name | Dlr Family Medicine Medical Group Pc |
|---|---|
| Speciality | Internal Medicine |
| Location | 11985 4th St Ste 102, Yucaipa, California |
| Authorized Official Name and Position | Darin L Rentz (PRESIDENT) |
| Authorized Official Contact | 7209847566 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Dlr Family Medicine Medical Group Pc 12 Calle Ameno San Clemente CA 92672-2346 Ph: (720) 984-7566 | Dlr Family Medicine Medical Group Pc 11985 4th St Ste 102 Yucaipa CA 92399-2727 Ph: (909) 478-7951 |
| NPI Number | 1295501708 |
|---|---|
| Provider Enumeration Date | 11/27/2023 |
| Last Update Date | 11/27/2023 |
| Medicare PECOS PAC ID | 0345683082 |
|---|---|
| Medicare Enrollment ID | O20240208004379 |
News Archive
The American Society for Radiation Oncology continued to advance its Target Safely initiative by participating in the Food and Drug Administration's public meeting on Device Improvements to Reduce the Number of Under-Doses, Over-Doses, and Misaligned Exposures from Therapeutic Radiation on June 9 and 10.
Valeant Pharmaceuticals International, Inc. today announced that it has withdrawn its offer to acquire ISTA Pharmaceuticals Inc. for $7.50 per share in cash.
A group of researchers, led by scientists at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, has shown that histone deacetylase (HDAC) inhibitors have the potential to eliminate stubborn reservoirs of breast and ovarian cancer stem cells (CSCs).
For at least some groups of "emerging adults," sleep problems are a predictor of chronic pain and worsening pain severity over time, suggests a study in PAIN, the official publication of the International Association for the Study of Pain.
To advance underdeveloped approaches to designing a preventive HIV vaccine, the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, is launching a new program to foster the study of B cells, immune cells that can produce antibodies with the capacity to neutralize HIV.
› Verified 6 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295501708 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | (* (Not Available)) | Primary |
| Provider Name | Rohit Hemant Godbole |
|---|---|
| Provider Type | Practitioner - Critical Care (intensivists) |
| Provider Identifiers | NPI Number: 1861758823 PECOS PAC ID: 3476868803 Enrollment ID: I20150814012619 |
News Archive
The American Society for Radiation Oncology continued to advance its Target Safely initiative by participating in the Food and Drug Administration's public meeting on Device Improvements to Reduce the Number of Under-Doses, Over-Doses, and Misaligned Exposures from Therapeutic Radiation on June 9 and 10.
Valeant Pharmaceuticals International, Inc. today announced that it has withdrawn its offer to acquire ISTA Pharmaceuticals Inc. for $7.50 per share in cash.
A group of researchers, led by scientists at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, has shown that histone deacetylase (HDAC) inhibitors have the potential to eliminate stubborn reservoirs of breast and ovarian cancer stem cells (CSCs).
For at least some groups of "emerging adults," sleep problems are a predictor of chronic pain and worsening pain severity over time, suggests a study in PAIN, the official publication of the International Association for the Study of Pain.
To advance underdeveloped approaches to designing a preventive HIV vaccine, the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, is launching a new program to foster the study of B cells, immune cells that can produce antibodies with the capacity to neutralize HIV.
› Verified 6 days ago
| Provider Name | Brandon D Jensen |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1821476797 PECOS PAC ID: 3779892120 Enrollment ID: I20230622002648 |
News Archive
The American Society for Radiation Oncology continued to advance its Target Safely initiative by participating in the Food and Drug Administration's public meeting on Device Improvements to Reduce the Number of Under-Doses, Over-Doses, and Misaligned Exposures from Therapeutic Radiation on June 9 and 10.
Valeant Pharmaceuticals International, Inc. today announced that it has withdrawn its offer to acquire ISTA Pharmaceuticals Inc. for $7.50 per share in cash.
A group of researchers, led by scientists at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, has shown that histone deacetylase (HDAC) inhibitors have the potential to eliminate stubborn reservoirs of breast and ovarian cancer stem cells (CSCs).
For at least some groups of "emerging adults," sleep problems are a predictor of chronic pain and worsening pain severity over time, suggests a study in PAIN, the official publication of the International Association for the Study of Pain.
To advance underdeveloped approaches to designing a preventive HIV vaccine, the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, is launching a new program to foster the study of B cells, immune cells that can produce antibodies with the capacity to neutralize HIV.
› Verified 6 days ago
News Archive
The American Society for Radiation Oncology continued to advance its Target Safely initiative by participating in the Food and Drug Administration's public meeting on Device Improvements to Reduce the Number of Under-Doses, Over-Doses, and Misaligned Exposures from Therapeutic Radiation on June 9 and 10.
Valeant Pharmaceuticals International, Inc. today announced that it has withdrawn its offer to acquire ISTA Pharmaceuticals Inc. for $7.50 per share in cash.
A group of researchers, led by scientists at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, has shown that histone deacetylase (HDAC) inhibitors have the potential to eliminate stubborn reservoirs of breast and ovarian cancer stem cells (CSCs).
For at least some groups of "emerging adults," sleep problems are a predictor of chronic pain and worsening pain severity over time, suggests a study in PAIN, the official publication of the International Association for the Study of Pain.
To advance underdeveloped approaches to designing a preventive HIV vaccine, the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, is launching a new program to foster the study of B cells, immune cells that can produce antibodies with the capacity to neutralize HIV.
› Verified 6 days ago
Rolinda Children Services, New Directions Clinic Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 35225 Avenue A, Suite 101, Yucaipa, CA 92399 Phone: 909-797-0096 Fax: 909-797-1456 | |
Medamerica Physician Solutions Pc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 33758 Yucaipa Blvd, Yucaipa, CA 92399 Phone: 909-795-9747 | |
Redlands Yucaipa Medical Group, Inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 33423 Yucaipa Blvd, Suite D, Yucaipa, CA 92399 Phone: 909-790-7070 | |
Terracina Medical Clinic Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 34636 County Line Rd, Suite 32, Yucaipa, CA 92399 Phone: 909-795-9355 Fax: 909-795-9439 | |
Health And Wellness Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 11711 Sand Canyon Rd, Ssb 101, Yucaipa, CA 92399 Phone: 909-389-3272 Fax: 909-389-0772 | |
Community Alliance Medical Group Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 34675 Yucaipa Blvd, Yucaipa, CA 92399 Phone: 909-850-2411 |